Drug Trial Radar · NCT04793958
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
Last checked: Nov 20, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
461
Actual
Start
Jun 24, 2021
Primary completion
Jan 16, 2026
Study completion Oct 23, 2026
Sponsor
- Lead sponsor
- Mirati Therapeutics Inc.Bristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Mar 11, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study CA239-0006 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab versus chemotherapy in the second-line treatment setting in patients with CRC with KRAS G12C mutation.
Conditions
- Advanced Colorectal Cancer
- Metastatic Colorectal Cancer
Interventions
MRTX849Drug
28 Day Cycle
CetuximabBiological
28 Day Cycle
mFOLFOX6 RegimenDrug
* Fluorouracil * Oxaliplatin * Folinic acid
FOLFIRI RegimenDrug
* Fluorouracil * Irinotecan * Folinic acid
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: 30 months
- Progression-free Survival (PFS)Time frame: 30 months
Locations
419 sites in 32 countries. Site status is shown where the registry gives one.
Local Institution - 010-855-E
Alabaster, Alabama
Local Institution - 010-855-B
Bessemer, Alabama
Local Institution - 010-855-D
Birmingham, Alabama
Local Institution - 010-855-A
Birmingham, Alabama
Local Institution - 010-855-F
Birmingham, Alabama
Local Institution - 010-855-C
Birmingham, Alabama
Local Institution - 010-855
Birmingham, Alabama
Local Institution - 010-996
Gilbert, Arizona
Local Institution - 010-566
Goodyear, Arizona
Local Institution - 010-989
Phoenix, Arizona
Local Institution - 010-978
Springdale, Arkansas
Local Institution - 010-573
Bakersfield, California
Local Institution - 010-979C
Chula Vista, California
Local Institution - 010-980
Fresno, California
Local Institution - 010-851
Fullerton, California
Local Institution - 010-979A
La Mesa, California
Local Institution - 010-958A
Los Angeles, California
Local Institution - 010-958
Los Angeles, California
Local Institution - 010-551
Los Angeles, California
Local Institution - 010-847
Newport Beach, California
Local Institution - 010-563
Redlands, California
Local Institution - 010-979B
San Diego, California
Local Institution - 010-979D
San Diego, California
Local Institution - 010-979
San Diego, California
Local Institution - 010-982
San Francisco, California
Local Institution - 010-561
Santa Monica, California
Local Institution - 010-571
Sylmar, California
Local Institution - 010-574
Torrance, California
Local Institution - 010-570
Whittier, California
Local Institution - 010-872-H
Aurora, Colorado
Local Institution - 010-810
Aurora, Colorado
Local Institution - 010-872-A
Boulder, Colorado
Local Institution - 010-872-E
Centennial, Colorado
Local Institution - 010-872-C
Colorado Springs, Colorado
Local Institution - 010-872
Denver, Colorado
Local Institution - 010-872-B
Denver, Colorado
Local Institution - 010-872-J
Lakewood, Colorado
Local Institution - 010-872-F
Littleton, Colorado
Local Institution - 010-872-G
Longmont, Colorado
Local Institution - 010-872-I
Pueblo, Colorado
Showing 40 of 419 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.